Portfolio
STORM Therapeutics
Global
Active Portfolio
Biotech
Location:
Cambridge, United Kingdom
Founded: 2015
Originating from the University of Cambridge in the UK, STORM Therapeutics has deep expertise in RNA-modifying enzymes (RMEs) and a drug discovery platform. It works to develop innovative new medicines targeting RMEs for cancer, inflammatory diseases and other conditions.
Other Portfolio Company
RegCell
California, USA, and Suita, Osaka, Japan
Metagen Therapeutics Co., Ltd.
Tsuruoka, Yamagata, Japan
Neusignal Therapeutics
Chuo, Tokyo, Japan
reverSASP
Koto, Tokyo, Japan
Sonire Therapeutics Co., Ltd.
Shinjuku, Tokyo, Japan
Qoly
Shinagawa, Tokyo, Japan
AIRNA
Massachusetts, USA
NovAccel
Tsuchiura, Ibaraki, Japan
Shinobi Therapeutics
California, USA, and Kyoto, Japan
CellFiber
Koto, Tokyo, Japan
